TCL Archive NIH Balks At Forming New Review Groups For NCI’s Program Grants; Guidelines Draft Ready For NCAB August 2, 1974
TCL Archive After Year-Long Review, Varmus Removes “Reasonable Pricing” Clause From CRADA April 14, 1995
TCL Archive ODAC Nixes Abraxane for Adjuvant Breast Cancer, While Genasense Falls Victim to Its Randomized Trial. September 8, 2006
TCL Archive In Brief: Panel To Select Breast Committee Forom 130 Nominations; Bristol Plans Move To Princeton December 6, 1991
